We also examined whether Regulator of G protein Signalling 16 (RGS16), which binds specifically to PCV2 ORF3 [14] and may be involved in oncogenic pathways [15, 16], modulates the effect of apoptin on melanoma growth. Here, RGS16 is linked to melanoma.